Matches in SemOpenAlex for { <https://semopenalex.org/work/W2001715164> ?p ?o ?g. }
- W2001715164 endingPage "143" @default.
- W2001715164 startingPage "133" @default.
- W2001715164 abstract "Patients with cancer are at increased risk of venous thromboembolism (vte). Anticoagulation therapy has been shown to prevent vte; however, unique clinical circumstances in patients with cancer can often complicate the decisions surrounding the administration of prophylactic anticoagulation. No national Canadian guidelines on the prevention of cancer-associated thrombosis have been published. We therefore aimed to develop a consensus-based, evidence-informed guideline on the topic. PubMed was searched for clinical trials and meta-analyses published between 2002 and 2013. Reference lists of key articles were hand-searched for additional publications. Content experts from across Canada were assembled to review the evidence and make recommendations. Low molecular weight heparin can be used prophylactically in cancer patients at high risk of developing vte. Direct oral anticoagulants are not recommended for vte prophylaxis at this time. Specific clinical scenarios, including renal insufficiency, thrombocytopenia, liver disease, and obesity can warrant modifications in the administration of prophylactic anticoagulant therapy. There is no evidence to support the monitoring of anti–factor Xa levels in clinically stable cancer patients receiving prophylactic anticoagulation; however, factor Xa levels could be checked at baseline and periodically in patients with renal insufficiency. The use of anticoagulation therapy to prolong survival in cancer patients without the presence of risk factors for vte is not recommended." @default.
- W2001715164 created "2016-06-24" @default.
- W2001715164 creator A5003569071 @default.
- W2001715164 creator A5010372361 @default.
- W2001715164 creator A5012281667 @default.
- W2001715164 creator A5018625771 @default.
- W2001715164 creator A5033475036 @default.
- W2001715164 creator A5039491225 @default.
- W2001715164 creator A5044433786 @default.
- W2001715164 creator A5050449094 @default.
- W2001715164 creator A5057587870 @default.
- W2001715164 creator A5059754739 @default.
- W2001715164 creator A5067540200 @default.
- W2001715164 creator A5073652700 @default.
- W2001715164 creator A5075361066 @default.
- W2001715164 creator A5076144713 @default.
- W2001715164 creator A5081425242 @default.
- W2001715164 creator A5089913686 @default.
- W2001715164 date "2015-04-01" @default.
- W2001715164 modified "2023-09-29" @default.
- W2001715164 title "Canadian Consensus Recommendations on the Management of Venous Thromboembolism in Patients with Cancer. Part 1: Prophylaxis" @default.
- W2001715164 cites W115752518 @default.
- W2001715164 cites W1506411149 @default.
- W2001715164 cites W1510585761 @default.
- W2001715164 cites W1552379166 @default.
- W2001715164 cites W1674009589 @default.
- W2001715164 cites W1806259071 @default.
- W2001715164 cites W1821404797 @default.
- W2001715164 cites W1920594391 @default.
- W2001715164 cites W1938806758 @default.
- W2001715164 cites W1964009311 @default.
- W2001715164 cites W1964233296 @default.
- W2001715164 cites W1968674569 @default.
- W2001715164 cites W1973509710 @default.
- W2001715164 cites W1975927544 @default.
- W2001715164 cites W1976182266 @default.
- W2001715164 cites W1978080273 @default.
- W2001715164 cites W1978766111 @default.
- W2001715164 cites W1990670070 @default.
- W2001715164 cites W1992300775 @default.
- W2001715164 cites W1996600303 @default.
- W2001715164 cites W1996650797 @default.
- W2001715164 cites W1999155888 @default.
- W2001715164 cites W2005468213 @default.
- W2001715164 cites W2012519169 @default.
- W2001715164 cites W2013564192 @default.
- W2001715164 cites W2015801929 @default.
- W2001715164 cites W2023692200 @default.
- W2001715164 cites W2026039226 @default.
- W2001715164 cites W2026895719 @default.
- W2001715164 cites W2028608222 @default.
- W2001715164 cites W2029888371 @default.
- W2001715164 cites W2031799746 @default.
- W2001715164 cites W2039511225 @default.
- W2001715164 cites W2040800118 @default.
- W2001715164 cites W2041113507 @default.
- W2001715164 cites W2041459472 @default.
- W2001715164 cites W2043306284 @default.
- W2001715164 cites W2045391434 @default.
- W2001715164 cites W2050624503 @default.
- W2001715164 cites W2055484908 @default.
- W2001715164 cites W2059152519 @default.
- W2001715164 cites W2064812181 @default.
- W2001715164 cites W2064982023 @default.
- W2001715164 cites W2076436938 @default.
- W2001715164 cites W2087879951 @default.
- W2001715164 cites W2091875598 @default.
- W2001715164 cites W2094871265 @default.
- W2001715164 cites W2097986908 @default.
- W2001715164 cites W2101131613 @default.
- W2001715164 cites W2103419160 @default.
- W2001715164 cites W2103969621 @default.
- W2001715164 cites W2106763942 @default.
- W2001715164 cites W2111139930 @default.
- W2001715164 cites W2113020324 @default.
- W2001715164 cites W2116435978 @default.
- W2001715164 cites W2118615533 @default.
- W2001715164 cites W2124101267 @default.
- W2001715164 cites W2125173086 @default.
- W2001715164 cites W2128668914 @default.
- W2001715164 cites W2131099415 @default.
- W2001715164 cites W2134683286 @default.
- W2001715164 cites W2137730697 @default.
- W2001715164 cites W2142386661 @default.
- W2001715164 cites W2147143600 @default.
- W2001715164 cites W2147406493 @default.
- W2001715164 cites W2149399319 @default.
- W2001715164 cites W2152672882 @default.
- W2001715164 cites W2152957190 @default.
- W2001715164 cites W2157164794 @default.
- W2001715164 cites W2157775050 @default.
- W2001715164 cites W2159407715 @default.
- W2001715164 cites W2162646310 @default.
- W2001715164 cites W2167494200 @default.
- W2001715164 cites W2220604058 @default.
- W2001715164 cites W2340367584 @default.
- W2001715164 cites W3021525014 @default.
- W2001715164 cites W3021978581 @default.